+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 1Year - 17Years
All Genders
ID07218523

Evaluating PLENVU4 Versus Sodium Picosulfate for Bowel Cleansing in Children Aged 1 to Under 18 Undergoing Colonoscopy

Led by Norgine · Updated on 2026-10-07

212

Participants Needed

46

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the effectiveness, safety, and tolerability of PLENVU4 compared to sodium picosulfate for bowel cleansing in children and teenagers under 18 years old who need a colonoscopy. Colonoscopy is an important procedure to diagnose and manage various digestive conditions, and having a clean bowel is essential for proper visualization during the exam. Participants will be randomly assigned to receive either PLENVU4 or sodium picosulfate as an oral solution, both given over two days in split doses. The study includes a screening period of up to 28 days, followed by a treatment period on Days 1 and 2, during which participants stay in a Clinical Research Unit for intervention administration and colonoscopy. After the colonoscopy, participants will be discharged on Day 2. A safety follow-up visit or call will take place around Day 9. During the study, participants will undergo evaluations including bowel cleansing assessments using the Boston Bowel Preparation Scale and Harefield Cleansing Scale. Researchers will also monitor any adverse events, serious adverse events, and participant responses to treatment. The total participation includes screening, treatment, colonoscopy, and follow-up, ensuring safety and measuring the success of bowel cleansing.

CONDITIONS

Brief Title

A Study to Investigate Bowel Cleansing With PLENVU® Compared to Sodium Picosulfate in Participants Aged 1 to < 18 Years of Age in Preparation for Colonoscopy

Research Team

A

Annabel Rigg

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here